Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation (NASDAQ:TELA)
Earnings Call Insights: TELA Bio, Inc. (TELA) Q4 2025 Management View Antony Koblish, Co-founder, CEO & Director, highlighted that 2025, ...
Saturday, May 9, 2026
Tag: NASDAQTELA
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.